| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
57,027 |
52,310 |
$18.63M |
| 36415 |
Collection of venous blood by venipuncture |
65,728 |
57,827 |
$13.10M |
| A9150 |
Non-prescription drugs |
51,093 |
23,631 |
$12.62M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
41,408 |
39,360 |
$6.96M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
41,797 |
40,123 |
$5.07M |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
19,366 |
10,570 |
$4.99M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
22,330 |
21,446 |
$4.61M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
16,214 |
15,155 |
$4.17M |
| 80053 |
Comprehensive metabolic panel |
85,784 |
80,633 |
$2.45M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
8,332 |
7,985 |
$1.76M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
8,783 |
8,581 |
$1.58M |
| 70450 |
Computed tomography, head or brain; without contrast material |
10,172 |
9,860 |
$1.47M |
| G0378 |
Hospital observation service, per hour |
937 |
863 |
$991K |
| 0682 |
|
259 |
257 |
$980K |
| 99499 |
|
600 |
410 |
$769K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,825 |
3,737 |
$721K |
| 71045 |
Radiologic examination, chest; single view |
23,376 |
22,413 |
$713K |
| 71046 |
Radiologic examination, chest; 2 views |
15,372 |
14,931 |
$647K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
11,382 |
10,327 |
$574K |
| Z7502 |
|
14,298 |
14,139 |
$538K |
| 0762 |
|
121 |
115 |
$502K |
| 0270 |
|
39,451 |
18,056 |
$476K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14,153 |
13,435 |
$471K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
91,572 |
84,755 |
$470K |
| 0250 |
|
4,367 |
1,989 |
$455K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,941 |
1,915 |
$429K |
| J3490 |
Unclassified drugs |
48,085 |
22,723 |
$425K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
7,753 |
7,623 |
$411K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
32,551 |
30,366 |
$403K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
11,091 |
9,971 |
$374K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,029 |
960 |
$347K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
9,580 |
8,974 |
$276K |
| S9484 |
Crisis intervention mental health services, per hour |
623 |
596 |
$272K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,863 |
2,805 |
$266K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
10,338 |
8,652 |
$248K |
| 99199 |
Unlisted special service, procedure or report |
1,424 |
1,193 |
$246K |
| 84484 |
|
24,048 |
21,792 |
$246K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,811 |
1,769 |
$246K |
| 70486 |
|
1,527 |
1,501 |
$240K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,114 |
4,390 |
$217K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
10,922 |
10,072 |
$214K |
| 73130 |
|
2,813 |
2,754 |
$208K |
| 0160 |
|
204 |
193 |
$199K |
| 73610 |
|
2,403 |
2,350 |
$198K |
| 73564 |
|
2,657 |
2,597 |
$186K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,772 |
3,605 |
$175K |
| 0360 |
|
235 |
165 |
$174K |
| 81001 |
|
26,034 |
24,885 |
$173K |
| 73630 |
|
2,844 |
2,786 |
$168K |
| 87081 |
|
2,741 |
2,685 |
$155K |
| 73030 |
|
1,921 |
1,871 |
$142K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
11,250 |
10,759 |
$142K |
| 82962 |
|
5,812 |
3,851 |
$137K |
| 83880 |
|
10,225 |
9,671 |
$125K |
| 73110 |
|
1,606 |
1,569 |
$111K |
| 81003 |
|
9,873 |
9,531 |
$111K |
| 83690 |
|
17,944 |
17,131 |
$105K |
| 84703 |
|
16,018 |
15,324 |
$103K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
12,000 |
11,611 |
$102K |
| 0949 |
|
1,011 |
817 |
$102K |
| 72170 |
|
823 |
806 |
$96K |
| 95811 |
|
462 |
460 |
$91K |
| 86885 |
|
2,638 |
2,523 |
$86K |
| 96376 |
|
2,540 |
1,935 |
$85K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,138 |
4,075 |
$84K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,161 |
3,659 |
$82K |
| 87077 |
|
3,244 |
3,117 |
$79K |
| 87040 |
|
6,311 |
5,612 |
$78K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,255 |
2,205 |
$76K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
425 |
425 |
$75K |
| 93971 |
|
1,677 |
1,637 |
$75K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
240 |
216 |
$74K |
| 0301 |
|
168 |
104 |
$70K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,864 |
2,798 |
$68K |
| 10060 |
|
576 |
558 |
$67K |
| 83605 |
|
8,812 |
8,265 |
$66K |
| 12001 |
|
508 |
501 |
$64K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,724 |
1,577 |
$63K |
| 76801 |
|
2,085 |
1,904 |
$62K |
| 73080 |
|
866 |
844 |
$60K |
| 0720 |
|
802 |
638 |
$58K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
136 |
132 |
$57K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
590 |
555 |
$55K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,961 |
1,909 |
$54K |
| 74018 |
|
969 |
943 |
$53K |
| A9270 |
Non-covered item or service |
10,310 |
3,538 |
$52K |
| 72131 |
|
473 |
467 |
$52K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
542 |
534 |
$52K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,181 |
1,167 |
$51K |
| 73590 |
|
729 |
712 |
$50K |
| 76376 |
|
958 |
940 |
$50K |
| Q0111 |
Wet mounts, including preparations of vaginal, cervical or skin specimens |
1,836 |
1,797 |
$49K |
| 81025 |
|
3,597 |
3,522 |
$48K |
| 84702 |
|
4,492 |
4,099 |
$47K |
| 73090 |
|
769 |
751 |
$47K |
| 0324 |
|
342 |
336 |
$45K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
621 |
584 |
$45K |
| 96112 |
|
280 |
280 |
$45K |
| Q4051 |
Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) |
57 |
30 |
$45K |
| 87631 |
|
1,042 |
1,029 |
$45K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,489 |
1,414 |
$45K |
| 76830 |
Ultrasound, transvaginal |
1,456 |
1,414 |
$45K |
| 83735 |
|
8,046 |
6,976 |
$41K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,427 |
1,059 |
$40K |
| 12011 |
|
382 |
371 |
$40K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,738 |
1,653 |
$39K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,752 |
2,713 |
$38K |
| 85610 |
|
9,183 |
8,716 |
$37K |
| 85730 |
|
6,499 |
6,283 |
$34K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
127 |
125 |
$33K |
| Z7610 |
|
4,323 |
1,950 |
$33K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
12,999 |
11,060 |
$32K |
| 85027 |
|
7,103 |
6,785 |
$31K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,871 |
2,805 |
$29K |
| 0760 |
|
475 |
417 |
$28K |
| 0710 |
|
251 |
241 |
$26K |
| 0121 |
|
12 |
12 |
$25K |
| 82803 |
|
931 |
878 |
$24K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
810 |
789 |
$24K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,106 |
1,087 |
$24K |
| 86901 |
|
4,800 |
4,612 |
$22K |
| 94644 |
|
1,380 |
1,315 |
$22K |
| J1815 |
Injection, insulin, per 5 units |
1,390 |
905 |
$22K |
| 86880 |
|
1,099 |
1,074 |
$21K |
| 73502 |
|
354 |
346 |
$20K |
| 0761 |
|
448 |
352 |
$20K |
| 12002 |
|
240 |
238 |
$17K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,577 |
1,535 |
$17K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,097 |
1,047 |
$17K |
| 93017 |
|
339 |
304 |
$16K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,527 |
6,015 |
$16K |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
138 |
136 |
$16K |
| 86141 |
|
2,835 |
2,713 |
$16K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
4,072 |
3,705 |
$15K |
| 85379 |
|
2,648 |
2,583 |
$15K |
| 86900 |
|
3,769 |
3,629 |
$14K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,030 |
1,954 |
$14K |
| 29125 |
|
566 |
538 |
$14K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
43 |
40 |
$13K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
34 |
32 |
$13K |
| 73140 |
|
127 |
125 |
$13K |
| 84145 |
|
1,789 |
1,737 |
$13K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,845 |
7,441 |
$12K |
| 90715 |
|
1,787 |
1,758 |
$12K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,022 |
1,009 |
$11K |
| 80061 |
Lipid panel |
919 |
854 |
$11K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,493 |
4,144 |
$10K |
| 0305 |
|
28 |
28 |
$10K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,591 |
3,953 |
$10K |
| 87186 |
|
2,714 |
2,621 |
$10K |
| 82550 |
|
1,126 |
1,023 |
$10K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
643 |
605 |
$9K |
| 0272 |
|
105 |
98 |
$8K |
| 76770 |
|
192 |
186 |
$8K |
| 85007 |
|
2,882 |
2,746 |
$8K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
266 |
236 |
$8K |
| 97750 |
|
595 |
329 |
$7K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,055 |
1,904 |
$7K |
| 85651 |
|
1,103 |
1,037 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
165 |
130 |
$7K |
| 93970 |
|
98 |
92 |
$7K |
| J2060 |
Injection, lorazepam, 2 mg |
2,436 |
2,136 |
$7K |
| 36430 |
|
13 |
12 |
$6K |
| 71250 |
|
52 |
52 |
$6K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,412 |
2,310 |
$6K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,607 |
2,510 |
$6K |
| 0370 |
|
21 |
20 |
$5K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,374 |
2,195 |
$5K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,384 |
1,302 |
$5K |
| 72100 |
|
93 |
92 |
$5K |
| 99401 |
|
195 |
137 |
$4K |
| 99153 |
Mod sedat endo service >5yrs |
73 |
72 |
$4K |
| 99152 |
|
25 |
25 |
$4K |
| 76870 |
|
137 |
132 |
$4K |
| Z4301 |
|
157 |
157 |
$4K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
243 |
240 |
$4K |
| 87147 |
|
491 |
481 |
$4K |
| 59025 |
Fetal non-stress test |
277 |
120 |
$4K |
| J2704 |
Injection, propofol, 10 mg |
670 |
624 |
$4K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
590 |
281 |
$3K |
| 0300 |
|
28 |
28 |
$3K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,332 |
1,281 |
$3K |
| 29515 |
|
128 |
123 |
$3K |
| 64400 |
|
15 |
13 |
$3K |
| J7050 |
Infusion, normal saline solution, 250 cc |
370 |
277 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,843 |
1,750 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,205 |
925 |
$2K |
| H1003 |
Prenatal care, at-risk enhanced service; education |
109 |
73 |
$2K |
| 82150 |
|
108 |
104 |
$2K |
| 73060 |
|
67 |
66 |
$2K |
| 70491 |
|
15 |
15 |
$2K |
| 84112 |
|
201 |
186 |
$2K |
| 73552 |
|
26 |
25 |
$2K |
| 95816 |
|
12 |
12 |
$2K |
| 0306 |
|
13 |
13 |
$2K |
| 94729 |
|
96 |
94 |
$2K |
| 96367 |
|
136 |
125 |
$2K |
| 70496 |
|
13 |
13 |
$2K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
15 |
15 |
$2K |
| 94726 |
|
93 |
91 |
$2K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
54 |
54 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
544 |
501 |
$2K |
| 70498 |
|
25 |
25 |
$2K |
| 0258 |
|
38 |
27 |
$2K |
| 80164 |
|
190 |
170 |
$1K |
| 87420 |
|
55 |
51 |
$1K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
509 |
443 |
$1K |
| 82010 |
|
169 |
155 |
$1K |
| 99070 |
|
124 |
88 |
$1K |
| J2785 |
Injection, regadenoson, 0.1 mg |
28 |
27 |
$1K |
| 74174 |
|
25 |
25 |
$1K |
| 84132 |
|
306 |
251 |
$1K |
| 88720 |
|
268 |
243 |
$1K |
| 71101 |
|
12 |
12 |
$1K |
| 0750 |
|
26 |
26 |
$907.94 |
| 94060 |
|
41 |
41 |
$828.12 |
| 87275 |
|
55 |
55 |
$768.28 |
| 29105 |
|
12 |
12 |
$677.41 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
298 |
278 |
$654.59 |
| 82140 |
|
71 |
66 |
$599.70 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
15 |
15 |
$562.37 |
| 84550 |
|
90 |
87 |
$509.69 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
189 |
162 |
$505.89 |
| J2560 |
Injection, phenobarbital sodium, up to 120 mg |
26 |
25 |
$464.81 |
| 82553 |
|
45 |
26 |
$464.67 |
| 94645 |
|
15 |
15 |
$420.10 |
| 84100 |
|
177 |
160 |
$380.58 |
| J1644 |
Injection, heparin sodium, per 1000 units |
123 |
65 |
$344.77 |
| 74019 |
|
13 |
13 |
$328.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
66 |
61 |
$273.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
12 |
12 |
$267.96 |
| 87276 |
|
55 |
55 |
$246.25 |
| J1630 |
Injection, haloperidol, up to 5 mg |
82 |
68 |
$206.12 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
14 |
13 |
$193.40 |
| J1953 |
Injection, levetiracetam, 10 mg |
45 |
38 |
$153.22 |
| 70487 |
|
14 |
12 |
$151.72 |
| J3486 |
Injection, ziprasidone mesylate, 10 mg |
13 |
13 |
$117.18 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
16 |
12 |
$75.17 |
| C1769 |
Guide wire |
25 |
24 |
$54.12 |
| 80178 |
|
15 |
14 |
$35.28 |
| 87070 |
|
13 |
12 |
$34.47 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
17 |
16 |
$17.65 |
| J3480 |
Injection, potassium chloride, per 2 meq |
16 |
13 |
$14.56 |
| J1836 |
Injection, metronidazole, 10 mg |
15 |
15 |
$12.19 |
| 90686 |
|
15 |
15 |
$8.38 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
14 |
14 |
$6.92 |
| 36600 |
|
15 |
15 |
$5.80 |
| 84295 |
|
12 |
12 |
$5.18 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
225 |
216 |
$0.58 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
66 |
61 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
15 |
14 |
$0.00 |
| 41899 |
Unlisted procedure, dentoalveolar structures |
12 |
12 |
$0.00 |
| 87205 |
|
14 |
12 |
$0.00 |